Michael Joner

Showing 1-20 of 41 articles

Early spontaneous reperfusion after acute myocardial infarction: true association with plaque phenotype or simple clinical observation?

Joner M, Seguchi M, Sato Y, Virmani R

October 1, 2021 | 10.4244/EIJV17I8A110

Coronary interventions

Clinical and angiographic outcomes of crossing techniques for coronary chronic total occlusions: the ISAR-CTO registry

Xhepa E, Cassese S, Ndrepepa G, Joner M, Kufner S, Aytekin A, Lahmann A, Voll F, Fusaro M, Pinieck S, Schunkert H, Kastrati A, Fusaro M

October 1, 2021 | 10.4244/EIJ-D-20-01248

Coronary interventions

Super high-pressure balloon versus scoring balloon to prepare severely calcified coronary lesions: the ISAR-CALC randomised trial

Rheude T, Rai H, Richardt G, Allali A, Abdel-Wahab M, Sulimov D, Mashayekhi K, Ayoub M, Cuculi F, Bossard M, Kufner S, Xhepa E, Kastrati A, Fusaro M, Joner M, Byrne R, Cassese S

August 27, 2021 | 10.4244/EIJ-D-20-01000

Coronary interventions

Clinical outcomes by optical characteristics of neointima and treatment modality in patients with coronary in-stent restenosis

Xhepa E, Bresha J, Joner M, Hapfelmeier A, Rivero F, Ndrepepa G, Nano N, Cuesta J, Kufner S, Cassese S, Bastante T, Aytekin A, Rroku A, García-Guimaraes M, Lahmann A, Pinieck S, Rai H, Fusaro M, Schunkert H, Pérez-Vizcayno M, Gonzalo N, Alfonso F, Kastrati A

August 6, 2021 | 10.4244/EIJ-D-20-00662

Mechanical circulatory support-assisted percutaneous coronary intervention: have we reached the point of no return?

Joner M, Sager H

February 5, 2021 | 10.4244/EIJV16I15A218

Coronary interventions

Preclinical investigation of neoatherosclerosis in magnesium-based bioresorbable scaffolds versus thick-strut drug-eluting stents

Nicol P, Bulin A, Castellanos M, Stöger M, Obermeier S, Lewerich J, Lenz T, Hoppmann P, Baumgartner C, Fischer J, Steiger K, Haude M, Joner M

December 4, 2020 | 10.4244/EIJ-D-19-00747

Reply: A word of caution on haemodynamic structural valve deterioration of the latest-generation balloon-expandable transcatheter aortic valves

Rheude T, Joner M

October 23, 2020 | 10.4244/EIJ-D-20-00313R

Coronary interventions

Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data

Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabaté M, Laugwitz K, Windecker S, Kastrati A, Serruys P

March 20, 2020 | 10.4244/EIJ-D-18-01080

Interventions for valvular disease

Predictors of haemodynamic structural valve deterioration following transcatheter aortic valve implantation with latest-generation balloon-expandable valves

Rheude T, Pellegrini C, Cassese S, Wiebe J, Wagner S, Trenkwalder T, Alvarez H, Mayr P, Hengstenberg C, Schunkert H, Kastrati A, Husser O, Joner M

February 20, 2020 | 10.4244/EIJ-D-19-00710

Clinical use of intracoronary imaging. Part 2: acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions

Johnson T, Räber L, Di Mario C, Bourantas C, Jia H, Mattesini A, Gonzalo N, de la Torre Hernandez J, Prati F, Koskinas K, Joner M, Radu M, Erlinge D, Regar E, Kunadian V, Maehara A, Byrne R, Capodanno D, Akasaka T, Wijns W, Mintz G, Guagliumi G

August 29, 2019 | 10.4244/EIJY19M06_02

Drug-free stents with Polyzene-F nanocoating: a promising compromise for those at high bleeding risk?

Koppara T, Joner M

July 19, 2019 | 10.4244/EIJV15I4A55

Comparison of acute thrombogenicity for magnesium versus stainless steel stents in a porcine arteriovenous shunt model

Lipinski M, Acampado E, Cheng Q, Adams L, Torii S, Gai J, Torguson R, Hellinga DG, Joner M, Harder C, Zumstein P, Finn A, Kolodgie F, Virmani R, Waksman R

January 18, 2019 | 10.4244/EIJ-D-17-00958

Optical coherence tomography revisited: imaging and imagination

Rai H, Cassese S, Joner M

November 20, 2018 | 10.4244/EIJV14I10A194

Stents and scaffolds

Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds

Joner M, Ruppelt P, Zumstein P, Lapointe-Corriveau C, Leclerc G, Bulin A, Castellanos M, Wittchow E, Haude M, Waksman R

October 12, 2018 | 10.4244/EIJ-D-17-00708

Interventions for valvular disease

International LAMPOON: first European experience with laceration of the anterior mitral valve leaflet prior to transseptal transcatheter mitral valve implantation

Kasel M, Rumpf M, Frangieh A, Mayr P, Joner M, Xhepa E, Lederman RJ, Greenbaum A, Khan J, Ott I, Deutsch O, Michel J

September 20, 2018 | 10.4244/EIJ-D-18-00201

Bifurcation lesions

Thrombogenicity at the jailed side branch ostia in the provisional stenting technique: insights from an in vitro model

Paradies V, Lu S, Ng J, Ang H, Joner M, Foin N

September 20, 2018 | 10.4244/EIJ-D-18-00003

Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions

Räber L, Mintz G, Koskinas K, Johnson T, Holm N, Onuma Y, Radu M, Joner M, Yu B, Jia H, Meneveau N, de la Torre Hernandez J, Escaned J, Hill J, Prati F, Colombo A, Di Mario C, Regar E, Capodanno D, Wijns W, Byrne R, Guagliumi G

August 24, 2018 | 10.4244/EIJY18M06_011

Coronary interventions

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

Cassese S, Ndrepepa G, Byrne R, Kufner S, Lahmann A, Mankerious N, Xhepa E, Laugwitz K, Schunkert H, Fusaro M, Kastrati A, Joner M

June 20, 2018 | 10.4244/EIJ-D-18-00024

Stents and scaffolds

Very late scaffold thrombosis: insights from optical coherence tomography and histopathology

Joner M, Nicol P, Rai H, Richter H, Foin N, Ng J, Cuesta J, Rivero F, Serrano R, Alfonso F

April 6, 2018 | 10.4244/EIJ-D-17-00353

Report of an ESC-EAPCI Task Force on the evaluation and use of bioresorbable scaffolds for percutaneous coronary intervention: executive summary

Byrne R, Stefanini G, Capodanno D, Onuma Y, Baumbach A, Escaned J, Haude M, James S, Joner M, Jüni P, Kastrati A, Oktay S, Wijns W, Serruys P, Windecker S

January 19, 2018 | 10.4244/EIJ20170912-01

Latest news

NEW ISSUE

State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more

October 20, 2021

STATE OF THE ART

Valve-in-valve TAVI: a practical overview

Giuseppe Tarantini et al.

October 20, 2021

AHEAD OF PRINT

TAVI in younger (<70 years old) patients: the AMTRAC registry

Guy Witberg et al.

October 22, 2021

AHEAD OF PRINT

Impact of LVOT calcification in transfemoral TAVI patients

L. Waldschmidt et al.

Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial

Hironori Hara et al.

October 22, 2021

AHEAD OF PRINT

Serum caffeine causes adenosine-induced FFR overestimation

Hideaki Tanaka et al.